Thursday, January 06, 2011 4:07:50 PM
- MNTA receives FDA Approval for mCopaxone
- FDA tells Teva probably easier to start over and try again on Lovenox
- MNTA share price exceeds $40+ for the first time on the news
- MNTA covered call sellers jump out of basement windows over their heartache of not listening to Dew's warnings.
2011 could be the year of Momentaaaaaaaa!!!!!!
10nis
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
